Hyperkalemia and Risk of CKD Progression: A Propensity Score-Matched Analysis.

Autor: Agiro A; AstraZeneca, Wilmington, Delaware., Cook E; Analysis Group, Inc., Boston, Massachusetts., Mu F; Analysis Group, Inc., Boston, Massachusetts., Greatsinger A; Analysis Group, Inc., New York, New York., Chen J; Analysis Group, Inc., Boston, Massachusetts., Zhao A; Analysis Group, Inc., Boston, Massachusetts., Louden E; Analysis Group, Inc., Boston, Massachusetts., Colman E; AstraZeneca, Wilmington, Delaware., Desai P; AstraZeneca, Wilmington, Delaware., Chertow GM; Stanford University School of Medicine, Stanford, California.
Jazyk: angličtina
Zdroj: Kidney360 [Kidney360] 2024 Dec 01; Vol. 5 (12), pp. 1824-1834. Date of Electronic Publication: 2024 Aug 09.
DOI: 10.34067/KID.0000000000000541
Databáze: MEDLINE